» Articles » PMID: 22744751

The Fanconi Anemia Pathway in Replication Stress and DNA Crosslink Repair

Overview
Publisher Springer
Specialty Biology
Date 2012 Jun 30
PMID 22744751
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Interstand crosslinks (ICLs) are DNA lesions where the bases of opposing DNA strands are covalently linked, inhibiting critical cellular processes such as transcription and replication. Chemical agents that generate ICLs cause chromosomal abnormalities including breaks, deletions and rearrangements, making them highly genotoxic compounds. This toxicity has proven useful for chemotherapeutic treatment against a wide variety of cancer types. The majority of our understanding of ICL repair in humans has been uncovered through analysis of the rare genetic disorder Fanconi anemia, in which patients are extremely sensitive to crosslinking agents. Here, we discuss recent insights into ICL repair gained using new repair assays and highlight the role of the Fanconi anemia repair pathway during replication stress.

Citing Articles

Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia.

Chen Z, Wu F, Li Y, Li L, Lei Y, Gao S J Exp Med. 2025; 222(3.

PMID: 39836085 PMC: 11748990. DOI: 10.1084/jem.20241248.


Gene loss in Antarctic icefish: evolutionary adaptations mimicking Fanconi Anemia?.

Shin S, Kim S, Kim H, Lee J, Kim J BMC Genomics. 2024; 25(1):1102.

PMID: 39558275 PMC: 11575085. DOI: 10.1186/s12864-024-11028-0.


Helicase HELQ: Molecular Characters Fit for DSB Repair Function.

Zhao Y, Hou K, Liu Y, Na Y, Li C, Luo H Int J Mol Sci. 2024; 25(16).

PMID: 39201320 PMC: 11355030. DOI: 10.3390/ijms25168634.


Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

Zhao Y, Zhang F, Zhang X, Li Z, Li Q, Ni T Regen Ther. 2023; 24:256-266.

PMID: 37534236 PMC: 10391600. DOI: 10.1016/j.reth.2023.07.004.


The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells.

Jang S, Kim J Cell Cycle. 2022; 21(14):1468-1478.

PMID: 35506981 PMC: 9278452. DOI: 10.1080/15384101.2022.2074200.


References
1.
Alter B, Greene M, Velazquez I, Rosenberg P . Cancer in Fanconi anemia. Blood. 2003; 101(5):2072. DOI: 10.1182/blood-2002-11-3597. View

2.
de Winter J, Joenje H . The genetic and molecular basis of Fanconi anemia. Mutat Res. 2008; 668(1-2):11-9. DOI: 10.1016/j.mrfmmm.2008.11.004. View

3.
Nojima K, Hochegger H, Saberi A, Fukushima T, Kikuchi K, Yoshimura M . Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 2005; 65(24):11704-11. DOI: 10.1158/0008-5472.CAN-05-1214. View

4.
Letessier A, Millot G, Koundrioukoff S, Lachages A, Vogt N, Hansen R . Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature. 2011; 470(7332):120-3. DOI: 10.1038/nature09745. View

5.
Bienko M, Green C, Crosetto N, Rudolf F, Zapart G, Coull B . Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science. 2005; 310(5755):1821-4. DOI: 10.1126/science.1120615. View